Stage IIIC Colorectal Cancer AJCC v7 Active Not Recruiting Phase 2 Trials for Regorafenib (DB08896)

IndicationStatusPhase
DBCOND0090390 (Stage IIIC Colorectal Cancer AJCC v7)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02368886Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal CancerTreatment